More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Treatment Commences in Cynatas World First Clinical Trial

May 16, 2017 at 12:10 AM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · May 16, 2017 at 12:10 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/treatment-commences-in-cynatas-world-first-clinical-trial

Cynata Therapeutics Limited on 6ix

Story so far

  • UK Regulatory Authority Approves Cynata GvHD Clinical TrialSep 19, 2016
  • Cynata Files Application to Commence Phase 1 Clinical TrialAug 1, 2016
  • Cynata Prepares for Phase 1 Clinical TrialJun 21, 2016

Earlier from Cynata Therapeutics

  • March 2017 Quarterly ReportApr 26, 2017
  • Cynata Advances to Pre-IND Meeting with US FDAApr 18, 2017
  • CYP Files for New Patent for Oncology ApplicationsApr 12, 2017
  • CYP in Collaboration on Acute Respiratory Distress SyndromeApr 10, 2017
  • Cynata Partner apceth GmbH & Co Completes Cymerus EvaluationMar 30, 2017

Later from Cynata Therapeutics

  • United States Patent for Core Cynata TechnologyJun 19, 2017
  • Cynata Files New Patent Application for Cymerus in OncologyJun 20, 2017
  • CYP MSC Data in Asthma Model Published in Sceintific JournalJun 22, 2017
  • Cynata Therapeutics GvHD Clinical Trial & Corporate ProgressJun 27, 2017
  • FDA Meeting Provides Clear Path for US Development PlansJul 4, 2017
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer